On July 22, Li Hui, deputy general manager of Shenzhen Stock Exchange, visited our company for research and guidance, accompanied by relevant leaders of Shenzhen Stock Exchange in Shanghai Center and Zhu Xiaoyan, Secretary of the Party Group and Director of Suzhou Industrial Park Financial Development and Risk Prevention Bureau.

       As a high-tech enterprise, we care for life and health by continuous improvement in product performance and quality and stay true to the aspiration "Satisfying surgeons and benefiting patients around the world with high quality products". We forge ahead and strive to bring more and better medical products for the world.

       During the visit, Mr. Liu Shouguo, chairman of Innolcon Medical, and Mr. Luo Wei, general manager of Innolcon Medical, introduced the company's development history, main product layout, R&D, production and revenue, as well as future long-term development plans to the research team.

       During the period, as the strategic partners of Innolcon Medical, the relevant project leaders of Huatai Securities Co., Ltd., BDO Accounting Firm and Grandall Law Firm, introduced the company's current overall planning progress to the research team.

       The research group gave us targeted guidance from a professional standpoint. At the same time, Li Hui introduced the basic situation of Shenzhen stock exchange, sector characteristics, regulation operation, professional services and capital market system. He said that Shenzhen stock exchange would always support the development of technological innovation-based enterprises and provid fast response, one-to-one professional services to the listed enterprises. In addition, he fully affirmed the achievements of Innolcon Medical in the past and cherished high hopes on future development.